Targeting B2-Receptors to Develop Obesity Therapeutics That Preserve Muscle Mass
- Stimulating the B2 adrenergic receptor to combat obesity
- Leveraging Atrogi’s GPCR discovery platform to discovery precise targets to manage metabolism
- Highlighting ATR-339 clinical data to demonstrate durable, muscle maintaining therapeutics